LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study
Objective: To investigate whether circulating LH levels could be used as an indicator for the timing of antagonist addition in GnRH antagonist protocol.Design: Retrospective cohort study.Setting: University-based hospital.Patients: A total of 567 women stimulated with recombinant FSH monotherapy in...
Main Authors: | Minghui Liu, Shan Liu, Lingxiu Li, Peng Wang, Huanhuan Li, Yuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00067/full |
Similar Items
-
Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
by: Shan Liu, et al.
Published: (2021-07-01) -
Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01) -
Effect of CD14/TLR4 antagonist on GnRH/LH secretion in ewe during central inflammation induced by intracerebroventricular administration of LPS
by: Karolina Haziak, et al.
Published: (2018-07-01) -
GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01) -
Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
by: Dan Zhang, et al.
Published: (2018-12-01)